Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation — C. Ying (1999) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation
Shared by
De Clercq Erik
KU Leuven
Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation
Article
1999
en
Authors
+2 more
CY
C. Ying
JP
Jos van Pelt
SY
S. H. Yap
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1989
Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds
Hideki Nakashima
,
Rudi Pauwels
,
Masanori Baba
,
Dominique Schols
,
Jan Desmyter
,
De Clercq Erik
Article
2020
The Use of Fluorescent Probes to Detect ROS in Photodynamic Therapy
Sulbha K. Sharma
,
Michael R Hamblin
Article
2015
Curious Discoveries in Antiviral Drug Development: The Role of Serendipity
De Clercq Erik
Article
2023
Methods of use of semiconductor nanocrystal probes for treating a material
Shimon Weiss
,
Marcel P. Bruchez
,
Paul Alivisatos
Article
2012
Highlights in Antiviral Drug Research: Antivirals at the Horizon
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.